NYSE:MPW - Medical Properties Trust Stock Price Target and Predictions

  • Consensus Rating: Buy
  • Consensus Price Target: $24.57
  • Forecasted Upside: 7.30 %
  • Number of Analysts: 6
  • Breakdown:
  • 0 Sell Ratings
  • 1 Hold Ratings
  • 4 Buy Ratings
  • 1 Strong Buy Ratings
$22.90
▲ +0.15 (0.66%)

This chart shows the closing price for MPW by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New Medical Properties Trust Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for MPW and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for MPW

Analyst Price Target is $24.57
▲ +7.30% Upside Potential
This price target is based on 6 analysts offering 12 month price targets for Medical Properties Trust in the last 3 months. The average price target is $24.57, with a high forecast of $26.00 and a low forecast of $23.00. The average price target represents a 7.30% upside from the last price of $22.90.

This chart shows the closing price for MPW for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart

Current Consensus is Buy

The current consensus among 6 investment analysts is to buy stock in Medical Properties Trust. This Buy consensus rating has held steady for over two years.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 9 buy ratings
  • 3 hold ratings
  • 0 sell ratings
7/31/2020
  • 0 strong buy ratings
  • 9 buy ratings
  • 3 hold ratings
  • 0 sell ratings
10/29/2020
  • 0 strong buy ratings
  • 9 buy ratings
  • 3 hold ratings
  • 0 sell ratings
1/27/2021
  • 0 strong buy ratings
  • 6 buy ratings
  • 2 hold ratings
  • 0 sell ratings
4/27/2021
  • 0 strong buy ratings
  • 7 buy ratings
  • 2 hold ratings
  • 0 sell ratings
7/26/2021
  • 0 strong buy ratings
  • 5 buy ratings
  • 2 hold ratings
  • 0 sell ratings
10/24/2021
  • 1 strong buy ratings
  • 5 buy ratings
  • 2 hold ratings
  • 0 sell ratings
12/23/2021
  • 1 strong buy ratings
  • 4 buy ratings
  • 2 hold ratings
  • 0 sell ratings
1/22/2022

Latest Recommendations

  • 1 strong buy ratings
  • 4 buy ratings
  • 1 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
1/20/2022MizuhoBoost Price Target$23.00 ➝ $26.00High
1/3/2022Deutsche Bank AktiengesellschaftDowngradeBuy ➝ Hold$27.00 ➝ $25.00Low
10/29/2021Raymond JamesBoost Price TargetStrong-Buy$25.00 ➝ $26.00Medium
10/27/2021Bank of AmericaUpgradeNeutral ➝ Buy$21.50 ➝ $24.00High
10/25/2021Raymond JamesInitiated CoverageStrong-Buy$25.00Medium
8/11/2021Royal Bank of CanadaUpgradeSector Perform ➝ Outperform$23.00Low
7/14/2021MizuhoReiterated RatingBuy$23.00Low
7/6/2021Bank of AmericaDowngradeBuy ➝ Neutral$21.50Low
6/14/2021Wolfe ResearchInitiated CoveragePeer Perform$23.00High
6/3/2021Deutsche Bank AktiengesellschaftBoost Price TargetBuy$25.00 ➝ $27.00Medium
5/10/2021Royal Bank of CanadaReiterated RatingOutperform ➝ Sector Perform$24.00 ➝ $23.00Low
5/3/2021Royal Bank of CanadaDowngradeOutperform ➝ Sector Perform$24.00 ➝ $23.00Medium
2/8/2021BarclaysBoost Price TargetOverweight$23.00 ➝ $25.00Medium
1/22/2021Truist FinancialDowngradeBuy ➝ Hold$21.00 ➝ $22.00Low
1/21/2021KeyCorpBoost Price TargetOverweight$22.00 ➝ $24.00Medium
12/15/2020Deutsche Bank AktiengesellschaftUpgradeHold ➝ Buy$24.00Medium
11/27/2020Truist FinancialBoost Price Target$20.00 ➝ $21.00Low
9/9/2020Colliers SecuritiesInitiated CoverageBuy$23.00Low
9/1/2020Stifel NicolausReiterated RatingBuy$21.00Low
8/24/2020MizuhoUpgradeNeutral ➝ Buy$20.00 ➝ $23.00Low
7/10/2020Deutsche Bank AktiengesellschaftDowngradeBuy ➝ Hold$23.00 ➝ $19.00Medium
6/25/2020SunTrust BanksBoost Price TargetBuy$19.00 ➝ $20.00Medium
4/23/2020SunTrust BanksLower Price TargetBuy$22.00 ➝ $19.00Low
4/21/2020KeyCorpLower Price TargetOverweight$25.00 ➝ $20.00High
4/3/2020Wells Fargo & CompanyLower Price TargetEqual Weight$21.00 ➝ $16.00Low
4/3/2020JPMorgan Chase & Co.Lower Price TargetOverweight$25.00 ➝ $20.00High
3/30/2020MizuhoDowngradeBuy ➝ Neutral$27.00 ➝ $19.00Low
3/23/2020Bank of AmericaUpgradeNeutral ➝ BuyHigh
3/18/2020BarclaysReiterated RatingBuy$22.00Medium
3/9/2020Royal Bank of CanadaReiterated RatingBuy$25.00Medium
1/16/2020KeyCorpBoost Price TargetOverweight$22.00 ➝ $23.00Medium
1/14/2020Robert W. BairdBoost Price TargetNeutral$20.00 ➝ $22.00Low
12/26/2019MizuhoBoost Price TargetBuy$25.00 ➝ $26.00Low
12/19/2019MizuhoInitiated CoverageBuy$25.00Medium
10/21/2019BarclaysSet Price TargetBuy$22.00Low
10/14/2019Bank of AmericaInitiated CoverageNeutral$19.50Low
9/12/2019Berenberg BankInitiated CoverageBuy$22.00Low
9/4/2019JPMorgan Chase & Co.Set Price TargetBuy$21.00Low
9/3/2019BarclaysInitiated CoverageOverweight$20.00High
8/27/2019SunTrust BanksBoost Price TargetBuy$20.00 ➝ $21.00High
8/12/2019Stifel NicolausSet Price TargetBuy$21.00Low
7/29/2019Deutsche Bank AktiengesellschaftUpgradeHold ➝ BuyLow
7/23/2019Stifel NicolausUpgradeHold ➝ Buy$18.00 ➝ $19.00High
7/2/2019SunTrust BanksUpgradeHold ➝ Buy$19.00 ➝ $20.00High
3/29/2019Deutsche Bank AktiengesellschaftBoost Price TargetHold ➝ Hold$14.00 ➝ $16.00High
2/13/2019Jefferies Financial GroupUpgradeHold ➝ Buy$18.00 ➝ $23.00Medium
2/11/2019Mitsubishi UFJ Financial GroupBoost Price TargetNeutral$17.00Low
12/19/2018JPMorgan Chase & Co.UpgradeNeutral ➝ OverweightLow
12/18/2018SunTrust BanksDowngradeBuy ➝ HoldMedium
12/11/2018Wells Fargo & CompanyUpgradeUnderperform ➝ Market Perform$13.50 ➝ $17.50Low
11/2/2018Mitsubishi UFJ Financial GroupBoost Price TargetNeutral$15.00Low
11/1/2018Stifel NicolausSet Price TargetHold$14.00Medium
10/1/2018JMP SecuritiesSet Price TargetBuy$16.00High
7/17/2018Jefferies Financial GroupDowngradeBuy ➝ Hold$15.00Medium
5/31/2018Wells Fargo & CompanyBoost Price TargetUnderperform ➝ Underperform$11.50 ➝ $13.00Low
3/19/2018Deutsche Bank AktiengesellschaftLower Price TargetHold ➝ Hold$13.50 ➝ $13.00High
1/10/2018Deutsche Bank AktiengesellschaftDowngradeBuy ➝ Hold$14.00 ➝ $13.50Low
1/5/2018Robert W. BairdDowngradeOutperform ➝ Neutral$15.00 ➝ $13.00Medium
12/15/2017JPMorgan Chase & Co.UpgradeUnderweight ➝ Neutral$14.50High
11/3/2017SunTrust BanksReiterated RatingBuy$15.00N/A
9/17/2017KeyCorpReiterated RatingHoldLow
8/29/2017Jefferies Financial GroupReiterated RatingBuy$15.00Low
7/28/2017Stifel NicolausReiterated RatingHold$13.00Low
7/24/2017Royal Bank of CanadaReiterated RatingBuy$16.00Medium
7/17/2017JMP SecuritiesUpgradeMarket Perform ➝ Outperform$14.00Medium
7/4/2017Jefferies Financial GroupUpgradeHold ➝ BuyMedium
7/4/2017Deutsche Bank AktiengesellschaftBoost Price TargetBuy$13.50 ➝ $15.00Medium
6/9/2017Jefferies Financial GroupReiterated RatingBuy ➝ Buy$15.00 ➝ $16.00Medium
5/15/2017Royal Bank of CanadaReiterated RatingBuyLow
4/7/2017Jefferies Financial GroupUpgradeHold ➝ Buy$13.00 ➝ $15.00Medium
4/6/2017Deutsche Bank AktiengesellschaftBoost Price TargetBuy$13.50 ➝ $15.00Low
3/9/2017Robert W. BairdInitiated CoverageOutperform ➝ Outperform$14.00Low
3/8/2017SunTrust BanksReiterated RatingBuyLow
2/16/2017BarclaysReiterated RatingEqual Weight$13.00 ➝ $14.00N/A
2/10/2017BarclaysBoost Price Target$14.00N/A
(Data available from 1/22/2017 forward)

News Sentiment Rating

0.98 (Buy)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
6/26/2021
  • 7 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
7/26/2021
  • 9 very positive mentions
  • 2 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
8/25/2021
  • 4 very positive mentions
  • 2 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
9/24/2021
  • 3 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
10/24/2021
  • 6 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
11/23/2021
  • 4 very positive mentions
  • 7 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
12/23/2021
  • 12 very positive mentions
  • 9 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
1/22/2022

Current Sentiment

  • 12 very positive mentions
  • 9 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Medical Properties Trust logo
Medical Properties Trust, Inc. is a self-advised real estate investment trust, which engages in the investment, acquisition, and development of net-leased healthcare facilities. Its property portfolio includes rehabilitation hospitals; long-term acute care hospitals; ambulatory surgery centers; hospitals for women and children; regional and community hospitals; medical office buildings; and other single-discipline facilities. The company was founded by Edward K. Aldag Jr., R. Steven Hamner, Emmett E. McLean, and William Gilliard McKenzie on August 27, 2003 and is headquartered in Birmingham, AL.
Read More

Today's Range

Now: $22.90
Low: $22.66
High: $22.98

50 Day Range

MA: $22.51
Low: $20.74
High: $24.13

52 Week Range

Now: $22.90
Low: $19.39
High: $24.13

Volume

4,338,026 shs

Average Volume

3,868,880 shs

Market Capitalization

$13.66 billion

P/E Ratio

23.85

Dividend Yield

4.92%

Beta

0.54

Frequently Asked Questions

What sell-side analysts currently cover shares of Medical Properties Trust?

The following equities research analysts have issued reports on Medical Properties Trust in the last twelve months: Bank of America Co., Barclays PLC, Deutsche Bank Aktiengesellschaft, KeyCorp, Mizuho, Raymond James, Royal Bank of Canada, TheStreet, Truist Financial Co., Wolfe Research, and Zacks Investment Research.
View the latest analyst ratings for MPW.

What is the current price target for Medical Properties Trust?

8 Wall Street analysts have set twelve-month price targets for Medical Properties Trust in the last year. Their average twelve-month price target is $24.25, suggesting a possible upside of 5.9%. Raymond James has the highest price target set, predicting MPW will reach $26.00 in the next twelve months. Truist Financial Co. has the lowest price target set, forecasting a price of $22.00 for Medical Properties Trust in the next year.
View the latest price targets for MPW.

What is the current consensus analyst rating for Medical Properties Trust?

Medical Properties Trust currently has 2 hold ratings, 4 buy ratings and 1 strong buy rating from Wall Street analysts. The stock has a consensus analyst rating of "Buy." A "buy" rating indicates that analysts believe MPW will outperform the market and that investors should add to their positions of Medical Properties Trust.
View the latest ratings for MPW.

What other companies compete with Medical Properties Trust?

How do I contact Medical Properties Trust's investor relations team?

Medical Properties Trust's physical mailing address is 1000 URBAN CENTER DRIVE SUITE 501, BIRMINGHAM AL, 35242. The real estate investment trust's listed phone number is (205) 969-3755 and its investor relations email address is [email protected] The official website for Medical Properties Trust is www.medicalpropertiestrust.com.